India medical device exports hit $4 billion in FY25, $35 billion opportunity by 2030
Synopsis
India's medical devices are no longer just cheap alternatives — they're becoming globally competitive products. A Bain & Company report pegs exports at $4 billion in FY25, reaching 125+ countries, and projects a $35 billion medtech market by 2030. The catch: scaling up clinical evidence and regulatory capability, not just manufacturing, will decide whether India converts this momentum into lasting global leadership.
Key Takeaways
India's medical device exports reached $4 billion in FY2025 , covering over 125 countries .
High-end medical device imports stood at $5.5 billion , signalling a major import-substitution opportunity.
Asia-Pacific medtech demand is projected to reach $132 billion by 2030 , growing at 6.9% annually .
Bain & Company identifies India as a $35 billion medtech opportunity by 2030 , with exports forecast to grow at over 20% CAGR to $8 billion .
India's healthcare market is expected to exceed $320 billion within a few years, growing at 10–12% CAGR .
The report flags gaps in clinical evidence generation , regulatory strategy , and commercialisation as the key barriers to the next growth phase.
India's medical device sector exported goods worth $4 billion in FY2025, reaching buyers in over 125 countries, as a new report by Bain & Company identified the country as the Asia-Pacific region's 'access-led innovator'. The findings, released on 8 July, place India at the centre of a fast-expanding regional medtech market projected to hit $132 billion by 2030.
Key Findings from the Report
The Bain & Company report — developed in partnership with the Agency for Science, Technology and Research, Enterprise Singapore (EnterpriseSG), JP Morgan, SG Growth Capital, and the Singapore Economic Development Board (EDB) — highlights a structural shift in how India's medtech sector is perceived globally. Devices designed for resource-constrained healthcare settings are increasingly finding acceptance in international markets, demonstrating that affordability and scalability can drive global competitiveness.
On the import side, high-end medical devices entering India stood at $5.5 billion, a figure the report frames as the next major opportunity for domestic innovation and import substitution.
Asia-Pacific Medtech: A $132 Billion Market
The Asia-Pacific region, with high-growth markets such as India at its core, is becoming one of the world's most significant demand centres for medical technology. Regional medtech demand is expected to reach $132 billion by 2030, expanding at 6.9% annually — a pace faster than the global market average. This comes amid rising incomes, ageing populations, and expanding healthcare infrastructure across the region.
Notably, the report cautions that the next phase of growth will depend not only on scaling manufacturing but also on building stronger capabilities in clinical evidence generation, regulatory strategy, commercialisation, and market access — areas where India currently lags behind more established medtech hubs.
India's $35 Billion Medtech Opportunity
Dhruv Sukhrani, Partner and Head of Bain & Company's Healthcare & Life Sciences practice in India, described the sector as a $35 billion medtech opportunity by 2030. He projected medical device exports growing at over 20% CAGR through 2030, potentially doubling to $8 billion.
'As the country moves towards becoming the world's third-largest economy, healthcare demand is expected to grow to over $320 billion in the next couple of years at a roughly 10–12% CAGR, creating strong momentum for medical technologies,' Sukhrani said.
He added: 'The next phase of growth, however, will be defined not just by manufacturing scale but by India's ability to build globally competitive innovation through stronger clinical evidence, regulatory capabilities and commercialisation.'
What Comes Next
The report's emphasis on regulatory and commercialisation gaps signals where policy and private investment must converge. India's medtech story, while compelling on export volumes, still hinges on closing a roughly $1.5 billion trade deficit between imports and exports of medical devices. As domestic healthcare spending accelerates toward the $320 billion mark, the pressure to build end-to-end innovation capability — not just cost-competitive manufacturing — will intensify.
Point of View
But the $5.5 billion import bill tells the fuller story — India remains a net importer of medical devices, particularly at the high-end. The Bain report's framing of India as an 'access-led innovator' is apt, but access-led is not the same as globally competitive. The 20% CAGR export target by 2030 will require more than manufacturing scale; without a credible domestic regulatory pathway and clinical trial infrastructure, Indian medtech companies will continue to face market access barriers in the US, EU, and Japan. The real policy test is whether the Centre's medtech push translates into investment in those unglamorous but critical capabilities.
NationPress
8 Jul 2026
Frequently Asked Questions
How much did India's medical device sector export in FY25?
India's medical device exports reached $4 billion in FY2025, according to a Bain & Company report released on 8 July. The country exported to over 125 countries and was identified as Asia-Pacific's 'access-led innovator'.
What is the projected size of India's medtech market by 2030?
Bain & Company projects India's medtech sector to be a $35 billion opportunity by 2030, with medical device exports expected to grow at over 20% CAGR to reach $8 billion. The broader Asia-Pacific medtech market is forecast to hit $132 billion by 2030.
Why does India still import more medical devices than it exports?
India imported $5.5 billion worth of high-end medical devices in FY25, compared to $4 billion in exports, reflecting a gap in advanced technology manufacturing. The Bain report identifies this deficit as the next major opportunity for domestic innovation and import substitution.
What are the key challenges India faces in growing its medtech sector?
According to the Bain & Company report, the next phase of growth will require India to build stronger capabilities in clinical evidence generation, regulatory strategy, commercialisation, and market access — not just scale up manufacturing. These gaps currently limit the global competitiveness of Indian medical device companies.
How large is India's overall healthcare market expected to become?
India's healthcare demand is expected to grow to over $320 billion within the next few years, expanding at a CAGR of roughly 10–12%, according to Dhruv Sukhrani, Partner and Head of Bain & Company's Healthcare & Life Sciences practice in India.
